Tocilizumab as a promising agent against COVID-19: Issues and challenges.

Dastan, Farzaneh; Tabarsi, Payam; Abedini, Atefeh; Saffaei, Ali

Dastan, Farzaneh; Tabarsi, Payam; Abedini, Atefeh; Saffaei, Ali.

Dastan F; Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tabarsi P; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abedini A; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saffaei A; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

J Res Med Sci ; 26: 80, 2021.

Article in English | MEDLINE | ID: covidwho-1472460

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: J Res Med Sci Year: 2021 Document Type: Article Affiliation country: Jrms.JRMS_524_20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google